News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

Political interference clips hedge funds' desires to trade on mega mergers

Outcome of merger deals harder to predict making funds less keen to bet on successful completions

A wave of megadeal activity in Europe isn't providing the trading opportunities many hedge funds had hoped for.

US drug firm Pfizer 's $120 billion attempt to buy UK rival AstraZeneca and General Electric's GE proposed $17 billion purchase of French group Alstom's power business are seen by many investors as kicking off a long-awaited boom in M&A in Europe.

WSJ Logo